Human Stem Cells Struck Me Instantly
Why did a veteran of global finance choose us for his final act? His essay records the moment. Working furiously in Singapore, he received a call from an old audit-firm acquaintance: a Japanese company aiming to list was seeking a CFO. A conversation he would normally decline — but something nagged, so he listened.
"I had never heard the words 'human stem cells,' but it clicked instantly. This business could change the world, give hope to many, and deliver smiles — I was convinced." A finance professional staked his final chapter on a field he had just heard of. Reckless?
His chapter's title explains everything: "Feeling the INSTINCT" — forty years of experience answering in a single instant. And he saw the people too: drawn to the energy of the team leading it. Conviction in the business, attraction to the people — the two reasons anyone ever boards a ship.
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
Next Essay
What Do You Work For? – A 64-Year-Old's Question
Read →About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.